TECX Q1 2022 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$399,000

Operating Income

-$29M

Net Income

-$30M

EPS (Diluted)

$-8.19

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$175M

Total Liabilities

$32M

Stockholders' Equity

$143M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$399,000	-$291,000	-37.1%
Operating Income	-$29M	-$27M	-9.4%
Net Income	-$30M	-$27M	-10.9%